Today

Agents

Chat

Arena

Discover

More

App

Zimmer Biomet Q2 Adjusted EPS USD 2.07 Vs. IBES Estimate USD 2.01 - ZBH News | Rallies

Zimmer Biomet Q2 Adjusted EPS USD 2.07 Vs. IBES Estimate USD 2.01

ZBH•2026-08-05

Zimmer Biomet reports second-quarter results and outlook

Aug. 5 (Reuters) - Zimmer Biomet Q2 sales USD 2,177 million vs. IBES estimate USD 2,134 million.

Q2 EPS USD 1.03
Q2 net income USD 198.3 million
Outlook FY adjusted EPS USD 8.47-8.59 vs. IBES estimate USD 8.48
Outlook FY revenue growth 3.9-4.9%

Related News

Trinity Capital's Q2 investment income rises

TRIN•2026-08-05

Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (Rmat) Designation For Lx2020

LXEO•2026-08-05

New York Times Co Outlook Q3 Digital-Only Subscription Revenues Increase 12% - 15%

•

2026-08-05

Cencora Enters Amended And Restated Credit Agreement On July 31, 2026 - SEC Filing

COR•2026-08-05

Beamr integrates NVIDIA Video Super Resolution into live sports, broadcast workflows

BMR•2026-08-05